Outcomes of a rigorous medical device study begun in 2012 and supported by Dr. Thomas Brandon and the Peninsula Orthopaedic Associates (POA) clinical research team has resulted in FDA approval for patient use of the Arthrex Eclipse Total Shoulder Replacement system effective August 1, 2019. POA was one of sixteen (16) national sites selected to participate in a research study that evaluated the effectiveness of a total shoulder replacement system, through Arthrex, a global leader in orthopedic surgical device designs, research, manufacturing and medical education.
Dr. Thomas Brandon, a primary investigator in the study stated, “We have participated in this randomized clinical research study since 2012 and each patient in the study was followed for 24 months after surgery. It has been a privilege to be part of this cutting-edge research and these significant advancements in shoulder replacements to provide better outcomes for our patients.” Dr. Brandon also mentioned, “the Eclipse Total Shoulder Replacement System replicates the true anatomy and function of the shoulder. With this advancement, this Eclipse system has several advantages such as: decreased operating time, reduced bone removal, and improved shoulder function, compared to other devices that utilize the traditional stemmed total shoulder arthroplasty.”
Arthrex commented, “The Eclipse system is a novel, less invasive, bone-preserving total shoulder replacement that has been clinically proven in Europe and Canada with more than 20,000 successful implantations over the past 14 years. The Eclipse system was the first total shoulder implant to replace traditional long stem fixation with short, fenestrated cage screw fixation for bone ingrowth, eliminating the need for bone cement. Its success as a total shoulder replacement has been demonstrated by outstanding long-term clinical results for the treatment of shoulder arthritis.”
About Peninsula Orthopaedic Associates
Peninsula Orthopaedic Associates is a multi-specialty orthopaedic practice that has been offering communities across the Delmarva Peninsula an expansive continuum of orthopaedic services since 1952. With offices in Berlin and Salisbury, Maryland and Millsboro and Seaford, Delaware, POA provides a broad spectrum of advanced orthopaedic treatments and diagnostic services including, foot and ankle, hand and elbow, hip and knee, shoulder, spine, sports medicine, joint replacement, joint preservation, and orthopaedic trauma care. POA is continuing to raise the bar of orthopaedic excellence with cutting edge clinical research trials and adding orthopaedic surgeons to elevate the level of care we provide. POA is honored to announce our newest physician to our team, Dr. Taylor Wiley, will be joining us starting September 3, 2019. Dr. Wiley will see patients at our multiple POA locations throughout the region. POA is also affiliated with the AAAHC accredited Deer Pointe Surgical Center and POA Physical Therapy located in Salisbury, Maryland.